May Cheng-Su Chen

Dr. Melinda Telli is an Associate Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine, Director of the Breast Cancer Program at the Stanford Cancer Institute and Associate Director of the Stanford Women's Cancer Center. Dr. Telli’s research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Her work has focused on the validation of homologous recombination deficiency biomarkers to help identify patients with sporadic triple-negative breast cancer that may specifically derive benefit from DNA repair defect-targeted therapies.

Stanford Shoor is a Clinical Professor of Medicine and Rheumatology at Stanford University. He has conducted clinical research in Rheumatology and Internal Medicine and has more than 65 publications in medical journals but his emphasis is teaching and patient care. He is a key clinical faculty member in the Rheumatology Fellowship program and heads the Divisions programs in resident and medical student education. He is the Course Director of Rheumatology Grand Rounds. His special interests are sarcoidosis, evidence based medicine, patient self-care and practice improvement.

Dr. Lin is a fellowship-trained endocrine surgeon who specializes in surgery of the thyroid, parathyroid, and adrenal glands. After receiving her undergraduate degree from Stanford University, Dr. Lin pursued her medical and surgical training on the east coast, where she completed her residency in general surgery at Rutgers Robert Wood Johnson Medical School and fellowship in endocrine surgery at the Harvard-affiliated Massachusetts General Hospital. Dr. Lin's clinical practice focuses on the surgical management of benign and malignant thyroid conditions, hyperparathyroidism, adrenal tumors, as well as melanoma and advanced skin cancers.